The Discounted Cash Flow (DCF) valuation of PTC Therapeutics Inc (PTCT) is (129.62) USD. With the latest stock price at 47.20 USD, the upside of PTC Therapeutics Inc based on DCF is -374.6%.
Based on the latest price of 47.20 USD and our DCF valuation, PTC Therapeutics Inc (PTCT) is a sell. selling PTCT stocks now will result in a potential gain of 374.6%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (283.21) - (88.73) | (129.62) |
| Upside | -700.0% - -288.0% | -374.6% |